Drug Interactions between Bydureon and Potiga
This report displays the potential drug interactions for the following 2 drugs:
- Bydureon (exenatide)
- Potiga (ezogabine)
Interactions between your drugs
No interactions were found between Bydureon and Potiga. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Bydureon
A total of 373 drugs are known to interact with Bydureon.
- Bydureon is in the drug class GLP-1 Agonists (Incretin Mimetics).
- Bydureon is used to treat Type 2 Diabetes.
Potiga
A total of 464 drugs are known to interact with Potiga.
- Potiga is in the drug class neuronal potassium channel openers.
- Potiga is used to treat the following conditions:
Drug and food interactions
exenatide food
Applies to: Bydureon (exenatide)
You should take exenatide twice a day, at any time within the 60 minutes (1 hour) before your morning and evening meals, or before the two main meals of the day, and at least 6 hours or more apart. You may experience decreased absorption of exenatide in the presence of food or other medications. Your other medications should be administered at least 1 hour before or 2 hours after your exenatide injection.
ezogabine food
Applies to: Potiga (ezogabine)
Alcohol can increase the blood levels of ezogabine and worsen side effects such as drowsiness, dizziness, nausea, constipation, difficulty urinating, blurred vision, memory impairment, and tremor. You should avoid or limit the use of alcohol while being treated with ezogabine. Also avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Ezogabine may be taken with or without food. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.